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a  b  s  t  r  a  c  t
Monitoring  consistency  of genetic  composition  of oral  polio  vaccine  (OPV)  is a part  of its  quality  control.
It is performed  by  mutant  analysis  by PCR  and  restriction  enzyme  cleavage  (MAPREC)  used to  quantify
neurovirulent  revertants  in the  viral  genome.  Here  an  alternative  method  based  on  quantitative  PCR
is proposed.  Allele-speciﬁc  quantitative  polymerase  chain  reaction  (asqPCR)  uses  a  “tethered”  oligonu-
cleotide  primer  consisting  of  two speciﬁc  parts  connected  by a polyinosine  stretch.  Homogeneous  DNA
from  plasmids  containing  wild Leon/37  and  attenuated  Sabin  3 sequences  with  100%  472C and  100%
472T could  only be  ampliﬁed  using  homologous  primers.  Real-time  implementation  of the  allele-speciﬁc
PCR  resulted  in  sensitive  detection  of  472C revertants  with  the  limit  of quantitation  of  less than  0.05%.
Monovalent  vaccine  batches  and  international  viral  references  for MAPREC  test  were  used to validate  theAPREC
lternative methods
method. asqPCR  performed  with  the  WHO  references  and  monovalent  batches  of vaccine  showed  that
the  new  method  could  measure  accurately  and  reproducibly  the  content  of revertants  producing  values
comparable  to MAPREC  results.  This  suggests  that  asqPCR  could  be used  as  an  alternative  to MAPREC  for
lot release  of  OPV.  The  method  could also be  used  for the  quantitation  of other  mutants  in  populations
of  microorganisms.
Published by Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY-NC-ND  license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).. Introduction
Viral replication is inherently error-prone and leads to emer-
ence of mutants. Their accumulation during manufacture of live
iral vaccines can lead to reversion of the attenuated phenotype and
lso to reduced immunogenicity by altering protective epitopes.
herefore changes in genetic composition of vaccine preparations
ould affect their safety and efﬁcacy. Even if present at a very low
evel, mutants can change signiﬁcantly the biological properties of
iruses. By using sensitive mutant analysis by PCR and restriction
nzyme cleavage (MAPREC) it was shown that all batches of oral
oliovirus vaccine (OPV) contain a small fraction of revertant viral
articles with increased neurovirulence (Chumakov et al., 1991). In
ome batches the content of these revertants was increased, result-
ng in failure of the monkey neurovirulence test used for vaccine
ot release. Therefore MAPREC was recommended as a quality con-
rol procedure to identify vaccine batches with unacceptably high
ontent of neurovirulent mutations.
∗ Corresponding author. Tel.: +1 301 594 3720; fax: +1 301 594 4622.
E-mail address: konstantin.chumakov@fda.hhs.gov (K. Chumakov).
ttp://dx.doi.org/10.1016/j.jviromet.2014.02.012
166-0934/Published by Elsevier B.V. This is an open access article under the CC BY-NC-NDespite its high sensitivity, MAPREC has a number of short-
comings: it is laborious and technically challenging, and requires
the use of radioactive isotopes. Therefore ﬁnding alternatives
remains a desirable objective. The main challenge is the difﬁculty
of detection and determining quantity of a very small fraction of
mutants in heterogeneous viral populations. A number of tech-
niques were used for this purpose, including matrix-assisted laser
desorption/ionization time of ﬂight (MALDI-TOF) mass spectrome-
try (Amexis et al., 2001), hybridization with microarrays of short
oligonucleotides (Laassri et al., 2011), and massively parallel or
deep sequencing (Neverov and Chumakov, 2010). These methods
were used successfully for detecting minor quantities of revertants
in the entire viral genomes. However they require sophisticated
and expensive equipment and the assays take a signiﬁcant time to
complete.
Quantitative PCR (qPCR) with Taqman probes has also been used
for studies of vaccine virus revertants in stool of vaccine recipients
and sewage samples (Gnanashanmugam et al., 2007; Troy et al.,
2011). However, the sensitivity of qPCR as measured by the min-
imum detectable percentage of mutants is relatively low. While
being acceptable for analysis of ﬁeld virus isolates that contain a sig-
niﬁcant proportion of mutants, it is not sufﬁcient for discriminating
acceptable batches of vaccine that contain less than 1% of mutants
D license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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rom unacceptable that contain slightly more than 1%. PCR proce-
ures for discrimination between mutants are based on primers
he 3′-end of which matches the nucleotide of interest. Terminal
ismatches reduce the ability of DNA-polymerase to initiate syn-
hesis, and therefore reduce efﬁciency of PCR. However, this
ethod is not absolutely allele-speciﬁc and even two  terminal mis-
atches do not guarantee full selectivity of the primers. Improve-
ent of binding speciﬁcity of PCR primers is an important goal
or many applications requiring discrimination between closely
elated sequences. Various primer modiﬁcations that decrease their
elting temperatures (Tm) and thus improve selectivity were
ested (Christopherson et al., 1997; Day et al., 1999; Kwok et al.,
990; Newton et al., 1989). However, while low-Tm primers may
iscriminate better between point mutants, their speciﬁcity is
ower and they tend produce additional artifactual DNA products.
To minimize the non-speciﬁc ampliﬁcation, a dual priming
ligonucleotide (DPO) system was proposed (Chun et al., 2007). In
he DPO system each primer consists of two segments, one being
onger than another, joined by a poly (I) linker. The shorter 3′-
erminal segment serves as a sensor of mutations similar to low-Tm
rimers, while the longer 5′-terminal segment increases the overall
tability of primer-template complexes and serves as an “anchor” to
revent the allele-speciﬁc 3′-end from binding unspeciﬁcally and
riming polymerase reaction at other loci. Polyinosine forms weak
omplexes with DNA, which are not sequence-speciﬁc. Therefore
he poly (I) linker serves as a ﬂexible connector between discrimi-
ating and stabilizing parts of the primer. Such “tethered” primers
ave a higher selectivity than primers without poly-I stretch. This
ystem was successfully used for detection of single-nucleotide
olymorphisms in cytochrome genes, but its results were quali-
ative.
Here we propose an adaptation of this principle to create an
llele-speciﬁc quantitative real-time method that we  call asqPCR
or accurate measurement of very small quantities of mutants in
atches of OPV. We  found that tethered primers have about 8-fold
igher selectivity and lead to a similar increase in the sensitivity
f mutant detection than regular primers. The content of virulent
eversion U472 → C in Sabin 3 poliovirus determined by asqPCR
atched closely the values determined by the industry-standard
APREC method. The new protocol is faster and simpler than
APREC assay and does not require the use of radioactive isotopes.
t could be used as an alternative for routine lot release of OPV, as
ell as for measuring quantities of mutants in other applications.
. Materials and methods
.1. Viruses and plasmids
To develop and assess the sensitivity of the asqPCR method,
lasmids containing the complete genome of Sabin 3 strain and
′ genome region (1–1567 nucleotide) of Leon/37 virus (wild type
 poliovirus) were used. Several viral preparations were used
or validation of the asqPCR method. They included US National
eurovirulence reference NC2 containing about 0.9% of U472 → C
utants, revertant Sabin 3 strain DM Pg35aP-396 isolated from
 vaccine recipient containing 100% of U472 → C (kindly provided
y Dr. Philip Minor, NIBSC, UK), two WHO  references (96/572 and
6/578) representing OPV lots that passed and failed MAPREC, and
ne batch of OPV3 that failed the monkey neurovirulence test.
.2. Construction of plasmid that contains U472 → C mutationTo construct a plasmid that contains U472 → C mutation, a
567 bp DNA fragment was ampliﬁed from 5 prime of Leon/37
irus genome with US-SP6 (Forward) and 1567Sab3RT7 (Reverse)
rimers (Table 1). The PCR amplicons were puriﬁed throughcal Methods 201 (2014) 86–92 87
1.5% agarose gel, extracted with QIAquick Gel Extraction
kit (Qiagen, Valencia, CA), and cloned into plasmid vector
pCR4-TOPO by using TOPO-TA Cloning kit (Invitrogen, Carlsbad,
CA). Approximately 100 ng of target amplicon was used in cloning
procedure. Transformed TOP10 Eschrichia coli cells were grown
overnight at 37 ◦C using an agar plates containing ampicillin,
IPTG (isopropyl-b-d-thiogalactopyranoside) and X-gal (5-bromo-
4-chloro-3-indolyl-b-dgalactopyranoside) (Fermentas, Hanover,
MD). White colonies were selected for the following analysis. A
QIAprep Spin MiniPrep kit (Qiagen, Valencia, CA) was  used for
isolation of plasmid DNAs in accordance with the manufacturer’s
protocol. Isolated plasmid DNA samples were analyzed by Sanger
method to conﬁrm their sequences.
2.3. Viral RNA extraction and cDNA preparation
Viral RNA was isolated from 140 l of virus containing medium
using the QIAamp Viral RNA Mini Kit (Qiagen, Valencia, CA)
according to the manufacturer’s protocol. The RNA was  eluted
to a ﬁnal volume of 60 l in sterile, RNase-free water. The cDNA
were prepared with Superscript III reverse transcriptase (Invitro-
gen, Carlsbad, CA) using the manufacturer’s protocol with speciﬁc
reverse primer 1567Sab3RT7 (Table 1).
2.4. Design of allele speciﬁc primers
The tethered allele primers speciﬁc for 472C and 472T were
designed to contain 3 parts: a longer 5′-segment targeting the
primer to a speciﬁc region on the template, polyinosine linker
between the speciﬁc segment and discriminating 3′-segment
designed for identiﬁcation of mutants by virtue of the 3′-terminal
nucleotide being complementary to the nucleotide of interest
(Fig. 1A, Table 1). Since the 3′ segment is responsible for primer
speciﬁcity, different sizes of this part were tested and the length of
5–6 nucleotides was found to produce the best results. In addi-
tion, a standard allele-speciﬁc primer without polyinosine liner
was made to evaluate the impact of primer modiﬁcations on the
discrimination between alleles (Table 1). Another forward primer
(“allele-nonspeciﬁc forward primer”) located immediately down-
stream from the allele speciﬁc primer was  designed to be used
for measuring DNA quantity for data normalization. The com-
mon for both strains reverse primer (“unmodiﬁed reverse primer”)
was used to produce 72 bp amplicon with allele speciﬁc primers
and 45 bp amplicon with allele-nonspeciﬁc forward primer. Both
forward and reverse allele-nonspeciﬁc primers had complete com-
plementarity to both mutant and wild type virus. Sequences of all
primers and their location on Sabin 3 genome are presented in
Table 1, and in the layout of primers in Fig. 1B.
2.5. Evaluation of discriminating ability of the allele-speciﬁc PCR
method
The developed allele-speciﬁc PCR was  designed to be very
selective because of high speciﬁcity of primers used as well as the
optimized PCR conditions. Brieﬂy, Sabin 3 and Leon/37 plasmid
DNAs were used as a template in a total reaction volume of
10 l containing 5 M of each of the above primers (Table 1),
50 M of each dNTP, 1.5 mM MgCl2, and 0.25 U HotStarTaq DNA
Polymerase (Qiagen, Valencia, CA). PCR was performed using a
9700 GeneAmp® PCR System (Applied Biosystems, Foster City,
CA) under the following dual stage conditions: 95 ◦C for 15 min,
followed by 10 cycles of 95 ◦C for 15 s, 68 ◦C for 50 s, 72 ◦C for 40 s,
then 20 cycles of 95 ◦C for 20 s, 62 ◦C for 50 s, 72 ◦C for 50 s. 5 l
of PCR product was separated by electrophoresis in 2% agarose
gels with ethidium bromide (Lonza, Rockland, ME). DNA  bands
in stained gels were assessed using Kodak Gel Logic 200 Imaging
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Table 1
Primers used for identiﬁcation of 472U → C mutants Sabin 3 virus.
Name Nucleotide (nt)
position
Polarity Sequence (5′ → 3′) Length, nt Tm (◦C)
Regular allele speciﬁc C primer 450–472 Forward CCGGCCCCTGAATGCGGCTAATC 23 65
Tethered allele speciﬁc C primer 450–472 Forward CCGGCCCCTGAAIIIIICTAATC 23 65
Tethered allele speciﬁc T primer 450–472 Forward CCGGCCCCTGAAIIIIICTAATT 23 65
Allele-nonspeciﬁc primer (F) 477–496 Forward CCATGGAGCAGGCAGCTGCA 20 63
Unmodiﬁed primer (R) 501–521 Reverse CGTTACGACAGGCTGGCTGCT 21 62
US-SP6 1–20 Forward ACCGGACGATTTAGGTGACACTATAGTTAAAACAGCTCTGGGGTTG 46 69
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ote: The mismatch nucleotide is shown in bold; underlined nucleotides correspon
ystem and Kodak Molecular Imaging Software (Carestream
ealth, Inc., Rochester, NY). The Sabin 3 plasmid was used as a nega-
ive control for PCR with tethered 472C-speciﬁc primer and Leon/37
lasmid as negative control for PCR with tethered 472T-speciﬁc
rimer.
.6. Sensitivity of the allele-speciﬁc quantitative PCR to evaluate
he revertant contents
To perform a quantitative analysis of revertants in addition to
iscriminating primers we have used an allele-nonspeciﬁc for-
ard primer (Table 1). PCR products made from Leon/37 and
rom Sabin 3 plasmids that contain 100% and 0% of U472 → C
evertants respectively were spiked in range 0.05–2% of Leon/37
lasmid and were run in triplicate in 5 separate experiments. The
piked samples were ampliﬁed by both pair of primers: tethered
72C-speciﬁc forward/non-modiﬁed reverse primers and allele-
on-speciﬁc forward/reverse primers, the ampliﬁcation with the
ater pair of primers served for data normalization. The Quan-
iFast SYBR Green PCR Kit (Qiagen, Valencia, CA) was  used for
eal-time PCR ampliﬁcation. The asqPCR procedure was  performed
sing Fast Real-Time PCR System 7900HT (Applied Biosystems,
oster City, CA) under the following dual stage PCR conditions:
5 ◦C for 5 min, followed by 10 cycles of 95 ◦C for 15 s, 68 ◦C
or 50 s, 72 ◦C for 40 s, then 20 cycles of 95 ◦C for 20 s, 62 ◦C for
0 s, 72 ◦C for 50 s. 1 mM EDTA was added in the reaction mix
o increase the speciﬁcity of ampliﬁcation. The obtained Ct val-
es were used to quantify the mutant’s content (in percent) using
he following formula: revertant contents = [(quantity of revertant
ontents in the sample)/(quantity of revertant contents in 100%
evertant control)] × 100. Since the efﬁciency of PCR ampliﬁcation
sing 472C-speciﬁc and 472T-speciﬁc primers was slightly differ-
nt, the results had to be normalized by using data obtained from
A
Template-speciﬁc
anchor segment
5 
B
C
472
Tetheredallele-
speciﬁc primer 
Allele-nonsp
forward prim
5’- 
450 477
ig. 1. (A) Design of tethered allele-speciﬁc primers consisting of 3′-terminal sensor segm
egment increasing stability of the primer-template complex. (B) Layout of tethered and CGACTCACTATAGGCATTCACA TATGGTAGGACAATA 48 67
e SP6 and T7 promoter sequences.
ampliﬁcation reactions with allele-insensitive forward and reverse
primers.
2.7. Validation of asqPCR method by the analysis of OPV
references
Two WHO  viral references (96/572 and 96/578) representing
oral polio vaccine lots that passed and failed the MAPREC test,
and containing about 0.7% and 1.1% of revertants respectively were
used for the asqPCR. To construct standard curves we used rever-
tant Sabin 3 strain DM Pg35aP-396 containing 100% 472C. Samples
tested include the US National neurovirulence reference NC2 with
about 0.9% of revertants and a failed vaccine batch (Lot F) contained
about 2.5% of 472C revertants. cDNA were synthesized from all
viral samples using the above protocol and ampliﬁed in the asqPCR
assay.
3. Results
3.1. Speciﬁcity of the allele speciﬁc primers
The general design of tethered allele-speciﬁc forward primers is
illustrated in Fig. 1A. The primers consist of three parts: the 3′-end
“sensor” segment is made of 6 nucleotides complementary to the
template. The 3′-terminal nucleotide of the segment matches the
mutation of interest, and therefore its ability to prime polymerase
reaction is affected signiﬁcantly by the mutation. The second part
is the ﬂexible ﬁve-nucleotide poly (I) linker connecting to the
third “anchor” segment that is complementary to the template
and serves to increase the stability of primer-template complexes.
This forward allele-speciﬁc primer is used together with a reverse
primer that does not have any modiﬁcations. Together they pro-
duce a 72 bp DNA amplicon (Fig. 1B).
Allele-discriminang 
segment
Poly (I) Linker
3
C/T
eciﬁc 
er 
Unmodiﬁed 
reverse primer
3’-
521501496
ent discriminating between alleles connected through poly-I linker to the anchor
allele-nonspeciﬁc primers used in asqPCR assay.
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Fig. 2. Speciﬁcity of the tethered allele speciﬁc primers. PCR DNA amplicons were
analyzed by electrophoresis in 2% agarose gel. Lanes 2–4: speciﬁc ampliﬁcation of
revertant type 3 poliovirus using tethered allele-speciﬁc forward primer for 472C
with Universal reverse primer: Lane 2, water (negative control); Lane 3, Sabin 3
strain; Lane 4, Leon/37 strain. Lanes 5–7: speciﬁc ampliﬁcation of type 3 vaccine
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Fig. 3. Dose–response curves of asqPCR assay: the Leon/37 plasmid DNA at con-
centrations ranging from 100 ng to 1 pg was quantiﬁed by asqPCR using tethered
allele-speciﬁc 472C forward/unmodiﬁed reverse primers (panel A) and allele-oliovirus using tethered allele-speciﬁc forward primer for 472T with unmodiﬁed
everse primer: Lane 5, water (negative control); Lane 6, Sabin 3 strain; Lane 7,
eon/37 strain. Lanes 1 and 8 contained 100 bp DNA Ladder.
To assess the discrimination of C revertant from non-revertant
 at position 472 plasmids with cDNA of Leon/37 (wild poliovirus)
ontaining 100% 472C and Sabin 3 strain containing 100% 472T
ere used. PCR was conducted using the dual temperature cycle
s described in Materials and Methods and primers speciﬁc for
72C and 472T. The results in Fig. 2 show that the 472C-speciﬁc
rimer generated one DNA band of proper size with the Leon/37
lasmid while the 472T-speciﬁc primer produced one speciﬁc DNA
and with Sabin 3 plasmid. No cross ampliﬁcation of mismatched
emplates was observed. The Sabin 3 DNA band had a lower
ntensity probably because of a lower melting temperature of the
-speciﬁc primer compared to the C-speciﬁc primer. These results
emonstrated that the tethered allele-speciﬁc primers used in the
ptimized dual temperature cycle produced a good speciﬁcity for
72T and 472C.
.2. Use of allele-speciﬁc primers for quantitative PCR (asqPCR)
The above results are in good agreement with the previously
ublished use of dual-priming oligonucleotides (Chun et al., 2007).
ince the limit of detection is determined by cross-ampliﬁcation
ecause of the insufﬁcient primer speciﬁcity, better discrimination
etween the two alleles could be used to lower the limit of detec-
ion and accurate quantitation of mutants. Therefore allele-speciﬁc
uantitative PCR (asqPCR) was developed in which the above teth-
red 472C and 472T-speciﬁc forward primers were used in pair with
he unmodiﬁed reverse primer (Table 1). PCR with another forward
rimer (“non-discriminating forward primer”) located inside the
mplicon was also performed to determine the quantity of the tem-
late that is used as a reference to normalize the results and make
hem comparable.The asqPCR was performed in a 96-well plate that was divided
n two equal parts: the ﬁrst included samples ampliﬁed by tethered
llele-speciﬁc primer, while the second part ampliﬁed with the
nmodiﬁed primers. The samples included a positive controlinsensitive forward/unmodiﬁed reverse primers (panel B).
with 100% 472C (wild-type or revertant), a negative control with
100% 472T (vaccine strain), a reference with known content of
mutants, and up to sixteen test samples. Each sample was  tested in
duplicate. The asqPCR was  performed in real-time format using the
ABI 7900HT thermocycler, and DNA ampliﬁcation monitored by
SYBR Green dye ﬂuorescence. The copy numbers were calculated
individually for each sample using parallel line analysis relative
to the reference standard, and normalized by dividing by copy
numbers obtained using non-discriminating primers.
The efﬁciency of PCR using C-allele-speciﬁc primer was higher
than with T-allele-speciﬁc primer (Fig. 2), making it difﬁcult to
compare their results quantitatively. Therefore, the content of
revertants was  determined using only the primer speciﬁc to 472C
by calculating the ratio between the copy number in the sample
with unknown percent of revertants to the copy numbers of 100%
revertants control, rather than the ratio between copy numbers of
revertant and non-revertant measured in experiments with two
different allele speciﬁc primers.
Dose–response curves were generated to determine the
efﬁciency and the limits of quantitative detection for both 472C-
speciﬁc and allele-non-speciﬁc primers (Fig. 3A and B). For both
primer sets Ct values increased linearly with template DNA in the
entire range tested between 1 pg and 100 ng. The ampliﬁcation
efﬁciency (A.E.) was  calculated as: A.E. = 10 (−1/b) − 1 (where b
is the slope of the linear regression). The A.E. was 1.08 and 1.11
for 472C-speciﬁc and allele-nonspeciﬁc primer sets, respectively.
Determination coefﬁcients (R2) were higher than 0.99 for both
primer sets. Since the linearity range was  at least 5 orders of mag-
nitude for both primer sets, the limit of the quantitative detection
could potentially be as low as 0.001% of revertants.
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4. Discussion
Virus strains used in the manufacture of viral vaccines undergo
mutational changes, which may  cause reversion of attenuated
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Experimental Values ig. 4. Allele discrimination between revertant (472C) and vaccine (472T) viruses b
ith  a regular allele-speciﬁc 472C forward/unmodiﬁed reverse primers (panel A) an
To evaluate the ability of the tethered 472C allele-speciﬁc primer
nd the regular 472C speciﬁc primer (without the polyinosine seg-
ent) (Table 1) to discriminate between C and T at nucleotide 472,
oth primers were used in separate reactions to amplify plasmid
NAs with 100% 472C and 100% 472T. The results presented in
ig. 4A and B demonstrated that the difference between Ct values
Ct) in ampliﬁcation plots of revertant DNAs and non-revertant
NAs was about 11 for the regular allele-speciﬁc primer (Fig. 4A)
nd about 14 for the tethered allele-speciﬁc primer (Fig. 4B). Thus
ross-ampliﬁcation of non-mutant DNA occurred at the frequency
f 2−11 for the regular allele-speciﬁc primer and 2−14 for teth-
red allele-speciﬁc primer. Therefore the cross-ampliﬁcation due to
is-priming results in the lower limit of detection of 2−11 = 0.05%
or regular, and 2−14 = 0.006% for tethered allel-speciﬁc primers,
espectively, increasing the sensitivity of detection by about 8 fold.
.3. Sensitivity of mutants quantitation by asqPCR assay
To evaluate the sensitivity of the asqPCR assay to quantify
utants, samples with different content of revertants were pre-
ared by spiking samples of Sabin 3 plasmid containing no 472C
ith varying quantities of Leon/37 plasmid containing 100% of
72C. The contents of mutants ranged between 0.05% and 2% were
repared and analyzed by asqPCR as described above. The results
f ﬁve independent experiments presented in Fig. 5 showed a good
orrelation between the expected mutant contents and the values
btained experimentally by asqPCR assay. We  found that the assay
as linear with R2 = 0.99 in the entire tested range, suggesting that
he range in which asqPCR may  be used for quantitative analysis is
t least 0.05%.
.4. asqPCR assay for the analysis of revertants in batches of OPV3
To validate the asqPCR assay and to determine whether its
esults are consistent with the MAPREC assay results, well-
haracterized viral and DNA reference samples were analyzed. They
ncluded the US neurovirulence reference NC2 and two WHO  ref-
rences for MAPREC assay of type 3 OPV. Each sample was tested inPCR method. Equal copy numbers of Leon/37 and Sabin 3 plasmids were ampliﬁed
hered allele-speciﬁc 472C forward/unmodiﬁed reverse primers (panel B).
triplicate in each experiment, and a total ﬁve independent experi-
ments were performed. The results presented in Table 2 show the
averages and the 95% conﬁdence intervals of the results. There was
a very good agreement between MAPREC and asqPCR results with
the correlation coefﬁcient of 0.999 (Fig. 6A). WHO  viral references
96/572 and 96/578 were selected based on their 472C content so
that they pass and fail, respectively, when tested in MAPREC assay
against the reference with the mutant content equal to the content
of 472C in the US neurovirulence reference NC2. Indeed, when we
have analyzed asqPCR results for these samples (Table 2 and Fig. 6B)
and used mutant content in NC2 as the reference (0.58 ± 0.03, C.I.
0.55–0.61), 96/572 passed (p = 0.033) and 96/578 failed (p = 0.007).
These results conﬁrm that asqPCR assay can be used as a simple and
rapid alternative to evaluate the quantity of the virulent mutation
(472C) in Sabin 3 of the oral polio vaccine.Fig. 5. Reproducibility and sensitivity of asqPCR for poliovirus type 3 revertants
(T472 → C) quantitation: the Leon/37 plasmid spiked into Sabin 3 plasmid samples
(in the 0.05–2% range) were subjected to asqPCR analysis. Each sample was analyzed
in  triplicates in ﬁve independent experiments.
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Table  2
Contents of 472-C in OPV 3 reference vaccine lots.
Sample ID Description Nominal 472-C content, %a Values observed in independent experiments, % Mean 95% CI
exp 1 exp 2 exp 3 exp 4 exp 5
WHO  96/572 WHO  reference passed vaccine 0.70 0.42 0.45 0.44 0.47 0.49 0.45 ± 0.03 0.42–0.49
NC-2  US neurovirulence reference 0.90 0.61 0.58 0.61 0.55 0.56 0.58 ± 0.03 0.55–0.61
WHO  96/578 WHO  reference failed vaccine 1.10 0.85 0.72 0.74 0.96 0.85 0.83 ± 0.10 0.70–0.95
Lot  F Failed vaccine lot 2.30 2.09 1.91 2.06 2.02 2.05 2.03 ± 0.07 1.94–2.11
exp: Experiment.
a Nominal mutant content was determined by MAPREC test.
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rig. 6. asqPCR assay for quantitation of 472C-revertants in type 3 OPV references. Ea
A)  correlation between the revertant contents in the WHO  references determined 
trains to virulence as well as to change the antigenic prop-
rties that affects the immunogenicity of inactivated vaccines
Gambaryan et al., 1998; Hughes et al., 2001; Schild et al., 1983).
herefore monitoring of the genetic consistency of vaccines is an
mportant task to ensure their quality, safety, and potency.
Sabin strains used in the manufacture of OPV represent a case
tudy of reversion of attenuated vaccine strains to virulence. Molec-
lar studies performed in the 1980s showed that U472 → C mutation
n Sabin type 3 virus (Cann et al., 1984), A481 → G mutation in type
 virus (Macadam et al., 1993), and G480 → A and U525 → C muta-
ions in type 1 virus (Christodoulou et al., 1990) accumulate during
irus growth in vitro and in vivo and are responsible for reversion
o virulence. Similar mutations are found in vaccine-derived strains
solated from cases of vaccine-associated paralytic polio, and there-
ore the presence of these revertants in batches of polio vaccine is
onsidered a safety risk. A method based on PCR and restriction
nzyme cleavage (MAPREC) was developed to identify batches of
ral Polio Vaccine (OPV) with unacceptable levels of neurovirulent
evertants (Chumakov, 1999; Chumakov et al., 1991), and was  rec-
mmended by WHO  as an in vitro method of choice for lot release
f OPV.
As mentioned in the introduction, MAPREC suffers from some
hortcomings including the need for radioactive isotopes and var-
ous technical challenges at multiple steps of its complex protocol.
uantitative PCR is an obvious alternative, but most quantitative
CR-based genotyping protocols either require expensive TaqMan
robes (Delobel et al., 2011; Germer et al., 2000; Kianianmomeni
t al., 2007; Laassri et al., 2005; Punia et al., 2004; Schwarz et al.,
004; Taira et al., 2011) or are not sensitive enough to quantity low
evels of mutants (less than 2%). This level of sensitivity is insufﬁ-
ient for analysis of viral vaccines with mutant contents of less than
%.
The method proposed in this communication is based on allele-
peciﬁc primers the speciﬁcity of which was enhanced by their
pecial design. The primers consist of three segments: the mutant-
iscriminating 3′-end linked by a ﬂexible poly-I stretch to a speciﬁc
egment that serves as an anchor to increase stability of bind-
ng and prevent non-speciﬁc priming. Such tethered allele-speciﬁc
rimers were developed previously for identiﬁcation of SNP (Chun
t al., 2007) but were not used for quantitative analysis. Here we
emonstrate that their speciﬁcity is about 8-fold higher than of
egular allele-speciﬁc primers, and consequently the lower limit oference sample was  tested by asqPCR in triplicates in ﬁve independent experiments.
PREC and asqPCR. (B) Contents of 472C-revertants in reference samples.
reliable detection and quantitation of mutants is also about 8-fold
lower. This improvement is signiﬁcant because the concentration of
mutants in OPV batches can be in the range where regular primers
demonstrate cross-ampliﬁcation. The proposed method is simple,
sensitive, and could be used to test 16 samples simultaneously
along with appropriate controls and reference samples.
Here we  describe the use of asqPCR for determining small quan-
tities of virulent mutants U472 → C in batches of type 3 OPV. Close
agreement between the results of asqPCR and MAPREC suggests
that asqPCR assay can be used as an alternative of MAPREC assay
for lot release of OPV. Importantly, the existing validated WHO  ref-
erences for MAPREC assay could be used for asqPCR test also. In
addition, the use of SYBR Green dye instead of expensive ﬂuores-
cent probes makes this method much easier to perform. The asqPCR
method is reproducible and is able to quantify with high accuracy
revertants present at a level as low as 0.05% and possibly beyond.
Similar primers were also developed for quantitation of mutants in
two other Sabin strains and are undergoing evaluation.
In conclusion, asqPCR could be considered as an alternative to
MAPREC for lot release of OPV. It also could be implemented for
monitoring consistency of other live viral vaccines as well as for
other applications requiring measuring low quantities of mutants.
For example, it could be used for discovery and quantitation of
mutants determining resistance of microorganisms to drugs and
antibodies. Sensitive quantitative analysis of mutants could be also
used in population and metagenomic studies.
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